No Data
No Data
Cerevel Ticks Higher as AbbVie Says It Expects Deal to Close Soon
Cerevel Therapeutics Gains as Investors Appear More Confident on FTC Approval for AbbVie
Cerevel Therapeutics Holdings(CERE.US) Director Sells US$1.03 Million in Common Stock
$Cerevel Therapeutics Holdings(CERE.US)$ Director COLES N ANTHONY sold 25,000 shares of common stock on Jul 1, 2024 at an average price of $41.1814 for a total value of $1.03 million.Source: Announcem
Cerevel Therapeutics Shares Are Trading Lower Amid Unconfirmed Rumors of a Recommendation Memo From FTC Staff to Challenge the AbbVie Merger.
Watching Cerevel Therapeutics; Traders Circulating M&A Blog Comments Saying A Recommendation Memo From The Staff At The FTC To "Challenge" The CERE/ABBV Merger Is Being Considered
U.S. FTC Sues To Block Tempur Sealy's Purchase Of Mattress Firm, Agency Says
No Data